|Posted by email@example.com on March 23, 2016 at 6:30 PM|
There is presently 21 patients entered in the Cimzia to Treat Interstitial Cystitis Study. Patients are getting better and no one has had a problem. Cimzia is a drug that is FDA approved to treat other autoimmune diseases. There is basic scientific research that demonstrates that Cimzia should improve the symptoms of patients with Interstitial Cystitis. Females between the age of 18 and 65 who have not responded to other treatments for Interstitial Cystitis are eligible for this study. Contact IC Study at 760 743-0532.